Lariago 40mg Injection
By Lariago
Rx
30ml Injection in a Vial

Composition
Chloroquine(40mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
July, 2025

liver
When using Lariago 40mg Injection, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when using Lariago 40mg Injection, so it is crucial to consult your doctor before starting the treatment. Your doctor may also recommend regular monitoring of your liver function tests while you are on this medication to ensure your liver is functioning properly.

kidney
Lariago 40mg Injection requires caution in individuals with kidney disease. Adjustments to the dosage may be necessary. It is recommended to seek advice from your healthcare provider prior to use.

alcohol
Consult your doctor when consuming alcohol with Lariago 40mg Injection.

driving
Caution should be exercised while driving as Lariago 40mg Injection may cause side effects like blurred vision or difficulty in focusing, which can impair driving ability.

pregnancy
Lariago 40mg Injection may not be safe during pregnancy. Limited human studies suggest potential harm to the baby. Animal studies show negative effects. Your doctor will assess risks versus benefits before prescribing. Please consult your doctor before use.

breastfeeding
Lariago 40mg Injection is considered safe to use during breastfeeding. Research shows the drug does not pass into breastmilk significantly, posing no harm to the baby.
Habit Forming | No |
Chemical Class | 4-Aminoquinoline Derivative |
Therapeutic Class | OPHTHAL |
Action Class | Antimalarial- Aminoquinolines |
₹52.5
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024